AGTC to Present at the 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 – Nasdaq
|
AGTC to Present at the 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017
Nasdaq AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop treatments designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's product pipeline … |
